Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Mitral valve replacement or repair in infective endocarditis: role of the isolated pathogens on mortality and early or late relapse rate
Anno:
2024
Background Mitral valve repair (MVr) is unquestionably superior to mitral valve replacement (MVR) in non-infective settings. European Society of Cardiology (ESC) and American Association for Thoracic Surgery guidelines recommend repair oxver replacement where possible even for endocarditis. Despite these recommendations, mitral valve repair rates are still low in this…
Single center experience in surgical treatment for active endocarditis before and after COVID-19 Pandemic
Anno:
2024
Background Despite advanced diagnosis and treatment, infective endocarditis (IE) is a potentially life-threatening condition. The impact of COVID-19 on diagnosis and outcome of surgical treatment of IE is uncertain. The aim of this study was to analyze the incidence, characteristics and outcomes of surgically treated IE before and after…
Not just a simple fever: diagnosis of complicated infective endocarditis on bicuspid aortic valve in a young man
Anno:
2024
Bicuspid aortic valve is the most common form of congenital heart disease (prevalence of 0.5 to 2.0%). These patients develop infective endocarditis at significantly higher rates than the general population; furthermore, they are at increased risk of developing infective endocarditis at a younger age owing to intrinsic factors of…
ROLE OF THE MOLECULAR TESTS FOR PATIENTS WITH INFECTIVE ENDOCARDITIS UNDERGOING CARDIAC SURGERY: AN EXPANDING HORIZON
Anno:
2024
Background Molecular tests have been proven to be a highly sensible tool to identify the pathogen of infective endocarditis (IE). However, their usefulness in the management of both blood culture positive and valve culture negative IE remains unclear. Methods We prospectively enrolled 100 consecutive patients with IE who underwent…